Double-blind efficacy and safety study comparing adinazolam mesylate and placebo in depressed inpatients-Reference-Cited by-同舟云学术

Double-blind efficacy and safety study comparing adinazolam mesylate and placebo in depressed inpatients

Published:1986-09 Issue:3 Volume:74 Page:238-245
ISSN:0001-690X
Container-title:Acta Psychiatrica Scandinavica
language:en
Short-container-title:Acta Psychiatr Scand

Author:

Smith W. T.,Glaudin V.

Publisher

Wiley

Subject

Psychiatry and Mental health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0447.1986.tb06239.x/fullpdf

Reference11 articles.

1. Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine

2. Sensitization of rat forebrain neurons to serotonin by adinazolam, an antidepressant triazolobenzodiazepine

3. 3. R A Lahti, R E Pyke, and V H Sethy . Adinazolam, a triazolobenzodiazepine antidepressant . Preclinical and clinical data. IUPHAR 9th International Congress of Pharmacology, London. 1984 (abstract 1983P).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Catatonia and melancholia interface: exploring a new paradigm for evaluation and treatment. A case series and literature review;Frontiers in Psychiatry;2024-03-20

2. Benzodiazepines as a Monotherapy in Depressive Disorders: A Systematic Review;Psychotherapy and Psychosomatics;2018

3. Identifying fast-onset antidepressants using rodent models;Molecular Psychiatry;2017-03-21

4. Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration?;Journal of Psychopharmacology;2008-05-30

5. Headache: One of the Most Common and Troublesome Adverse Reactions to Drugs;Current Drug Safety;2006-01-01